Reviewing the progression in Drug Designing research
Reviewing the progression in Drug Designing research
The team “Drug Designing: Open Access”, welcomes you to the most accessed “open access publication – Longdom Publishing” page with 25+ Million reader base.
The Journal of Drug Designing: Open Access progresses forward reviewing and disseminating the recent advances in pharmaceutical industry with focus towards the drug discovery, drug design by rational approach. Longdom Publishing hosts around 215 open access peer-reviewed journals as well as organizes more than 100 International scientific Conferences.
The Journal of Drug Designing: Open Access is a peer-reviewed journal accepting research papers on topics related to drug discovery, drug design by rational approach, target-based design, drug synthesis, drug metabolism, structure-based drug design, molecular modeling, ligand-based interaction, development of the generic drug, in silico chemoinformatics and bioinformatics technologies, receptor agonist/antagonist, protease substrate/inhibitor, peptidomimetic, Quality by design, Design for reliability in drug development, Design for traditional Chinese medicine clinical trials, Bayesian sequential design for multi-regional design, Design and analysis for target clinical trials, Design and analysis for diagnostic procedures, Adaptive design for early clinical development, Design for biosimilar studies, Design for bioassay development and validation, Design for statistical genetics, Design for assessment of drug to drug interaction, Design for bridging studies, Design for stability analysis.
Heading towards our 7th Volume we are glad to accept your valuable science communications including original research articles, systematic reviews, short note communications, case reports, editorials, letters to the Editors and expert opinions & commentaries from different regions for publication experiences and worthy outcomes.
A standard online link is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
The journal publishes the articles under open access policy with creative commons attribution license [CC-BY-NC 4.0] permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.
In addition to archiving, the published articles are also promoted through various scientific and social media as well as through International indexation and abstracting services.
Regards,
Reviewing the progression in Drug Designing research
The team “Drug Designing: Open Access”, welcomes you to the most accessed “open access publication – Longdom Publishing” page with 25+ Million reader base.
The Journal of Drug Designing: Open Access progresses forward reviewing and disseminating the recent advances in pharmaceutical industry with focus towards the drug discovery, drug design by rational approach. Longdom Publishing hosts around 215 open access peer-reviewed journals as well as organizes more than 100 International scientific Conferences.
The Journal of Drug Designing: Open Access is a peer-reviewed journal accepting research papers on topics related to drug discovery, drug design by rational approach, target-based design, drug synthesis, drug metabolism, structure-based drug design, molecular modeling, ligand-based interaction, development of the generic drug, in silico chemoinformatics and bioinformatics technologies, receptor agonist/antagonist, protease substrate/inhibitor, peptidomimetic, Quality by design, Design for reliability in drug development, Design for traditional Chinese medicine clinical trials, Bayesian sequential design for multi-regional design, Design and analysis for target clinical trials, Design and analysis for diagnostic procedures, Adaptive design for early clinical development, Design for biosimilar studies, Design for bioassay development and validation, Design for statistical genetics, Design for assessment of drug to drug interaction, Design for bridging studies, Design for stability analysis.
Heading towards our 7th Volume we are glad to accept your valuable science communications including original research articles, systematic reviews, short note communications, case reports, editorials, letters to the Editors and expert opinions & commentaries from different regions for publication experiences and worthy outcomes.
A standard online link is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
The journal publishes the articles under open access policy with creative commons attribution license [CC-BY-NC 4.0] permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.
In addition to archiving, the published articles are also promoted through various scientific and social media as well as through International indexation and abstracting services.
Regards,
Sherry Peterson
Journal Manager
Journal of Drug Designing: Open Access
WhatsApp: +1-947-333-4405
Reviewing the progression in Drug Designing research
The team “Drug Designing: Open Access”, welcomes you to the most accessed “open access publication – Longdom Publishing” page with 25+ Million reader base.
The Journal of Drug Designing: Open Access progresses forward reviewing and disseminating the recent advances in pharmaceutical industry with focus towards the drug discovery, drug design by rational approach. Longdom Publishing hosts around 215 open access peer-reviewed journals as well as organizes more than 100 International scientific Conferences.
The Journal of Drug Designing: Open Access is a peer-reviewed journal accepting research papers on topics related to drug discovery, drug design by rational approach, target-based design, drug synthesis, drug metabolism, structure-based drug design, molecular modeling, ligand-based interaction, development of the generic drug, in silico chemoinformatics and bioinformatics technologies, receptor agonist/antagonist, protease substrate/inhibitor, peptidomimetic, Quality by design, Design for reliability in drug development, Design for traditional Chinese medicine clinical trials, Bayesian sequential design for multi-regional design, Design and analysis for target clinical trials, Design and analysis for diagnostic procedures, Adaptive design for early clinical development, Design for biosimilar studies, Design for bioassay development and validation, Design for statistical genetics, Design for assessment of drug to drug interaction, Design for bridging studies, Design for stability analysis.
Heading towards our 7th Volume we are glad to accept your valuable science communications including original research articles, systematic reviews, short note communications, case reports, editorials, letters to the Editors and expert opinions & commentaries from different regions for publication experiences and worthy outcomes.
A standard online link is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
The journal publishes the articles under open access policy with creative commons attribution license [CC-BY-NC 4.0] permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.
In addition to archiving, the published articles are also promoted through various scientific and social media as well as through International indexation and abstracting services.
Regards,
Sherry Peterson
Journal Manager
Journal of Drug Designing: Open Access
WhatsApp: +1-947-333-4405
Journal Manager
Journal of Drug Designing: Open Access
WhatsApp: +1-947-333-4405